The neuromorphic computing specialist BrainChip has announced a significant commercial milestone, signaling a potential turnaround after a prolonged period of limited news. The company entered into a global licensing agreement with EDGEAI over the weekend, granting access to its next-generation Akida-2 technology. This deal reinforces a fundamental recovery that was initially hinted at in the firm’s latest annual revenue figures.
Under the terms of the non-exclusive partnership, EDGEAI receives comprehensive access to the intellectual property underpinning BrainChip’s Akida architecture. The agreement also includes necessary development tools and software components. Financial returns for BrainChip will come through milestone-based payments linked to technical delivery targets. Once EDGEAI begins commercial shipment of its own products, quarterly royalty payments will commence. While management has not yet quantified the precise financial scope, it anticipates substantial long-term revenue streams from resulting product sales.
Should investors sell immediately? Or is it worth buying BrainChip?
Financial Performance Shows Marked Improvement
This new contract aligns with a broader positive shift in the company’s financial trajectory. The annual report for 2025, published in late February, revealed a dramatic 374 percent surge in revenue to $1.89 million. Concurrently, BrainChip managed to narrow its net loss from $24.43 million to $20.47 million. The company also strengthened its balance sheet, with cash reserves growing to $31.71 million. Investor sentiment has responded with cautious optimism. The equity, currently trading at €0.09, is attempting to stabilize following an approximate 28 percent decline over the preceding twelve-month period.
Operational Milestones on the Horizon
Beyond commercial deals, operational execution is now coming into focus. The company reports that its AKD1500 chip has entered the volume production phase, with final silicon expected in the third quarter of 2026. In parallel, development has commenced on the custom AKD2500 project. First prototypes for this chip are also slated for availability in Q3 2026. These technological advancements form the foundation for BrainChip to more broadly address rising demand for ultra-low-power AI applications within the edge computing sector.
Ad
BrainChip Stock: Buy or Sell?! New BrainChip Analysis from March 31 delivers the answer:
The latest BrainChip figures speak for themselves: Urgent action needed for BrainChip investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 31.
BrainChip: Buy or sell? Read more here...
